FAGGIN, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 3.889
AS - Asia 1.041
EU - Europa 918
SA - Sud America 259
AF - Africa 240
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 12
Totale 6.380
Nazione #
US - Stati Uniti d'America 3.765
SG - Singapore 347
CN - Cina 227
DE - Germania 213
HK - Hong Kong 170
BR - Brasile 167
IT - Italia 139
FI - Finlandia 103
PL - Polonia 57
GB - Regno Unito 51
FR - Francia 46
SE - Svezia 44
VN - Vietnam 44
RU - Federazione Russa 36
UA - Ucraina 30
IN - India 26
CI - Costa d'Avorio 22
AT - Austria 20
NL - Olanda 20
EC - Ecuador 19
CA - Canada 17
AR - Argentina 16
JO - Giordania 16
MX - Messico 15
RO - Romania 14
TR - Turchia 13
AF - Afghanistan, Repubblica islamica di 12
BO - Bolivia 12
ES - Italia 12
MU - Mauritius 12
IE - Irlanda 11
IQ - Iraq 10
KG - Kirghizistan 10
PE - Perù 10
PH - Filippine 10
CV - Capo Verde 9
ID - Indonesia 9
LA - Repubblica Popolare Democratica del Laos 9
NC - Nuova Caledonia 9
SK - Slovacchia (Repubblica Slovacca) 9
TN - Tunisia 9
UZ - Uzbekistan 9
VE - Venezuela 9
ZA - Sudafrica 9
AO - Angola 8
DO - Repubblica Dominicana 8
HR - Croazia 8
MZ - Mozambico 8
SA - Arabia Saudita 8
TZ - Tanzania 8
YT - Mayotte 8
ZM - Zambia 8
AE - Emirati Arabi Uniti 7
EE - Estonia 7
EG - Egitto 7
GR - Grecia 7
IS - Islanda 7
JP - Giappone 7
KR - Corea 7
LC - Santa Lucia 7
LY - Libia 7
MA - Marocco 7
MK - Macedonia 7
MN - Mongolia 7
PY - Paraguay 7
TJ - Tagikistan 7
UY - Uruguay 7
AZ - Azerbaigian 6
BA - Bosnia-Erzegovina 6
BE - Belgio 6
CD - Congo 6
CG - Congo 6
CR - Costa Rica 6
DK - Danimarca 6
DZ - Algeria 6
ET - Etiopia 6
GH - Ghana 6
GP - Guadalupe 6
GT - Guatemala 6
IR - Iran 6
KE - Kenya 6
LB - Libano 6
MD - Moldavia 6
MW - Malawi 6
NP - Nepal 6
PR - Porto Rico 6
SD - Sudan 6
SI - Slovenia 6
TH - Thailandia 6
XK - ???statistics.table.value.countryCode.XK??? 6
YE - Yemen 6
ZW - Zimbabwe 6
AD - Andorra 5
AM - Armenia 5
BF - Burkina Faso 5
BY - Bielorussia 5
BZ - Belize 5
CM - Camerun 5
GE - Georgia 5
GF - Guiana Francese 5
Totale 6.176
Città #
Fairfield 607
Ashburn 353
Chandler 301
Ann Arbor 293
Houston 292
Woodbridge 272
Cambridge 203
Singapore 198
Seattle 194
Wilmington 166
Hong Kong 164
Jacksonville 90
Boardman 84
Munich 78
Santa Clara 71
Des Moines 70
Princeton 70
Beijing 61
San Diego 58
Bytom 46
Helsinki 37
Padova 37
Nanjing 34
Medford 32
Los Angeles 29
Roxbury 29
Abidjan 22
Turku 20
Ho Chi Minh City 17
Amman 16
Buffalo 16
Nürnberg 16
Guangzhou 15
Hanoi 15
New York 14
Venice 13
Brooklyn 12
Vienna 11
Guayaquil 10
Milan 10
Shenyang 10
Dublin 9
Falls Church 9
Hebei 9
Hefei 9
Lima 9
London 9
Noumea 9
Nuremberg 9
Praia 9
Redondo Beach 9
São Paulo 9
Tashkent 9
Bishkek 8
Kharkiv 8
Luanda 8
Nanchang 8
Vientiane 8
Castries 7
Dar es Salaam 7
La Paz 7
Lusaka 7
Mamoudzou 7
Phoenix 7
Toronto 7
Ulan Bator 7
Accra 6
Chicago 6
Dallas 6
Harare 6
Jiaxing 6
Jinan 6
Johannesburg 6
Kinshasa 6
Montevideo 6
Norwalk 6
Ogden 6
Warsaw 6
Andorra la Vella 5
Boston 5
Brazzaville 5
Dakar 5
Dushanbe 5
Frankfurt am Main 5
Kabul 5
Kingstown 5
Maputo 5
Minsk 5
Niamey 5
Port Louis 5
Pristina 5
Reykjavik 5
Santo Domingo 5
Seoul 5
Tallinn 5
Tunis 5
Zagreb 5
Abu Dhabi 4
Addis Ababa 4
Aden 4
Totale 4.469
Nome #
Impact of hypertension on vascular remodeling in patients with psoriatic arthritis 219
Clones of Interstitial Cells From Bovine Aortic Valve Exhibit Different Calcifying Potential When Exposed to Endotoxin and Phosphate 191
Atorvastatin Reduces Macrophage Accumulation in Atherosclerotic Plaques. A Comparison of a Nonstatin-Based Regimen in Patients Undergoing Carotid Endarterectomy. 189
Amiodarone impairs trafficking through late endosomes inducing a Niemann-Pick C-like phenotype 185
Common hepatic lipase gene promoter variant predicts the degree of neointima formation after carotid endarterectomy: impact of plaque composition and lipoprotein phenotype. 181
Atherosclerosis progression in psoriatic arthritis patients despite the treatment with tumor necrosis factor-alpha blockers: A two-year prospective observational study. 176
Warfarin, but not rivaroxaban, promotes the calcification of the aortic valve in ApoE−/− mice 174
The effects of basic fibroblast growth factor in an animal model of acute mechanically induced right ventricular hypertrophy. 170
Lipoprotein remnants and dense LDL are associated with features of unstable carotid plaque: A flag for non-HDL-C 164
Chronic kidney disease is associated with increased risk of venous thromboembolism recurrence 161
L-Arginine prevents inflammatory and pro-calcific differentiation of interstitial aortic valve cells 150
Developing an instrument for an early prediction model of long-term functional outcomes in people with acquired injuries of the central nervous system: protocol and methodological aspects 144
Proteomic analysis of clonal interstitial aortic valve cells acquiring a pro-calcific profile. 140
Is apoptosis of vascular smooth muscle cells involved in the development of Takayasu arteritis? Suggestions from a case report 137
RANKL Expression Is Increased in Circulating Mononuclear Cells of Patients with Calcific Aortic Stenosis 137
Atorvastatin Reduces Circulating Osteoprogenitor Cells and T-Cell RANKL Expression in Osteoporotic Women: Implications for the Bone-Vascular Axis 137
Cholesterol-Lowering Action of a Novel Nutraceutical Combination in Uremic Rats: Insights into the Molecular Mechanism in a Hepatoma Cell Line 135
Innate immunity and atherogenesis 133
Lipoprotein remnants and dense LDL are associated with features of unstable carotid plaque: A flag for non-HDL-C 133
Prevalence of fetal-type smooth muscle cells in the media of microvessels from hypertensive patients 128
Fibroblast growth factor 23 and the bone-vascular axis: lessons learned from animal studies. 128
Association between the -514 C to T polymorphism of the hepatic lipase gene promoter and unstable carotid plaque in patients with severe carotid artery stenosis 128
CONTRIBUTION OF ADVENTITIAL FIBROBLASTS TO NEOINTIMA FORMATION AND VASCULAR REMODELING: FROM AN INNOCENT BYSTANDER TO ACTIVE PARTICIPANT 126
Aortic valve calcification in chronic kidney disease 123
In vivo noninvasive identification of cell composition of intimal lesions: a combined approach with ultrasonography and immunocytochemistry. 115
Fish oil supplementation prevents neointima formation in non- hypercholesterolemic balloon-injured rabbit carotid artery by reducing medial and adventitial cell activation 114
Extracellular pyrophosphate is reduced in aortic interstitial valve cells acquiring a calcifying profile: Implications for aortic valve calcification 113
Is apoptosis of vascular smooth muscle cells involved in the development of Takayasu arteritis? Suggestions from a case report. 110
Predictors of vascular remodelling in hypertensive subjects with well-controlled blood pressure levels. 109
Serum uric acid levels and the risk of recurrent venous thromboembolism 109
Current evidence and future perspectives on pharmacological treatment of calcific aortic valve stenosis 108
The Multicentre Atorvastatin Plaque Stabilisation (MAPS) Study 105
The emerging role of nutraceuticals in cardiovascular calcification: Evidence from preclinical and clinical studies 104
Lipid Profile and Vascular Remodelling in Young Dyslipidemic Subjects Treated with Nutraceuticals Derived from Red Yeast Rice 102
Proteomic analysis of clonal interstitial aortic valve cells acquiring a pro-calcific profile 101
Myosin gene expression and cell phenotypes in vascular smooth muscle during development, in experimental models and in vascular disease. 101
Statin treatment and carotid plaque composition: A review of clinical studies 99
Low CD34+cells, high neutrophils and the metabolic syndrome are associated with an increased risk of venous thromboembolism 94
Smooth muscle-specific SM22 protein is expressed in adventitial cells of ballon-injured rabbit carotid. 93
Osteoprotegerin in Cardiovascular Disease:Ally or Enemy? 92
Carotid elasticity is impaired in stage 1 hypertensive patients with well-controlled blood pressure levels 91
A miR-125/Sirtuin-7 pathway drives the pro-calcific potential of myeloid cells in diabetic vascular disease 89
Serum uric acid levels and the risk of recurrent venous thromboembolism 86
Subclinical atherosclerosis in patients with psoriatic arthritis: the impact of classical and new cardiovascular risk factors 80
Atorvastatin Reduces Macrophage Accumulation in the Atherosclerotic Plaque: A Comparison versus Non-statin Based Regimen in Patients Undergoing Carotid Endarterectomy 79
Endotoxin and phosphate may contribute to valve calcification by inducing an osteogenic profile in a specific subset of interstitial aortic valve cells 78
Low-dose cerivastatin inhibits spontaneous atherogenesis in heterozygous Watanabe hyperlipidemic rabbits 77
Biomarkers of Neutrophil Activation in Patients with Symptomatic Chronic Peripheral Artery Disease Predict Worse Cardiovascular Outcome 74
NETosis in Acute Thrombotic Disorders 69
Subclinical atherosclerosis in patients with psoriatic arthritis: the impact of blood pressure 65
Therapeutic angiogenesis with recombinant bFGF: a potential strategy for the treatment of critical lower limb ischemia 64
Cholesterol-lowering action of a novel nutraceutical combination in uremic rats: Insights into the molecular mechanism in a hepatoma cell line 59
New markers of accelerated atherosclerosis in end-stage renal disease 55
Hypertension and vascular calcification: a vicious cycle? 53
The Role of Neutrophils in Lower Limb Peripheral Artery Disease: State of the Art and Future Perspectives 41
Antibodies against integrin αvβ6 have high diagnostic accuracy for ulcerative colitis 17
Totale 6.435
Categoria #
all - tutte 22.770
article - articoli 22.770
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.540


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021526 0 0 17 49 14 59 32 63 74 115 72 31
2021/2022738 9 56 134 53 37 43 39 71 29 15 104 148
2022/2023604 108 61 6 80 109 96 3 42 60 10 27 2
2023/2024251 15 35 40 23 10 20 25 12 15 8 18 30
2024/20251.224 5 47 50 62 165 27 46 106 111 51 206 348
2025/20261.284 227 422 635 0 0 0 0 0 0 0 0 0
Totale 6.435